| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695680 | Gynecologic Oncology | 2017 | 5 Pages |
Abstract
No statistically significant association was observed between metformin use and overall survival in a matched cohort of 360 ovarian cancer patients. However, exploratory modeling suggests metformin use may be protective in a certain subgroup of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Christine Garcia, Aaron Yao, Fabian Camacho, Rajesh Balkrishnan, Leigh A. Cantrell,